Your browser doesn't support javascript.
loading
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives.
Massimino, Michele; Stella, Stefania; Tirrò, Elena; Pennisi, Maria Stella; Vitale, Silvia Rita; Puma, Adriana; Romano, Chiara; DI Gregorio, Sandra; Tomarchio, Cristina; DI Raimondo, Francesco; Manzella, Livia.
Affiliation
  • Massimino M; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy michedot@yahoo.it.
  • Stella S; Center of Experimental Oncology and Hematology, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
  • Tirrò E; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Pennisi MS; Center of Experimental Oncology and Hematology, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
  • Vitale SR; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • Puma A; Center of Experimental Oncology and Hematology, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
  • Romano C; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • DI Gregorio S; Center of Experimental Oncology and Hematology, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
  • Tomarchio C; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
  • DI Raimondo F; Center of Experimental Oncology and Hematology, A.O.U. Policlinico Vittorio Emanuele, Catania, Italy.
  • Manzella L; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Anticancer Res ; 40(5): 2457-2465, 2020 May.
Article de En | MEDLINE | ID: mdl-32366389
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie myéloïde chronique BCR-ABL positive / Protéines proto-oncogènes c-abl / Protéines de fusion bcr-abl / Inhibiteurs de protéines kinases / Thérapie moléculaire ciblée / Antinéoplasiques Limites: Humans Langue: En Journal: Anticancer Res Année: 2020 Type de document: Article Pays d'affiliation: Italie
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie myéloïde chronique BCR-ABL positive / Protéines proto-oncogènes c-abl / Protéines de fusion bcr-abl / Inhibiteurs de protéines kinases / Thérapie moléculaire ciblée / Antinéoplasiques Limites: Humans Langue: En Journal: Anticancer Res Année: 2020 Type de document: Article Pays d'affiliation: Italie